Effect of Vioxx on adipose tissue development in mice with genetically determined obesity

Thromb Haemost 2008; 100(05): 954
DOI: 10.1160/TH08-05-0299

Letters to the Editor

Schattauer GmbH

H. Roger Lijnen

¹Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

References
1 Fajas L, Miard S, Briggs MR. et al. Selective cyclooxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase. J Lipid Res 2003; 44: 1652-1659.
2 Kellinsalmi M, Parikka V, Risteli J. et al. Inhibition of cyclooxygenase-2 down-regulates osteoclast differentiation and favours adipocyte formation in vitro. Eur J Pharmacol 2007; 572: 102-110.
3 Yan H, Kermouni A, Abdel-Hafez M. et al. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J Lipid Res 2003; 44: 424-429.
4 Fain JN, Ballou LR, Bahouth SW. Obesity is induced in mice heterozygous for cyclooxygenase-2. Prostaglandins Other Lipid Mediat 2001; 65: 199-209.
5 Lijnen HR, Van Hoef B, Lu HR. et al. Rofecoxib impairs adipose tissue development in a murine model of nutritionally induced obesity. Thromb Haemost 2008; 100: 338-342.
6 Fain JN, Kanu A, Bahouth SW. et al. Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 467-473.